TOPICA Pharmaceuticals' Series B - II Round

TOPICA Pharmaceuticals raised a round of funding on June 10, 2013.

TOPICA Pharmaceuticals is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, fungal infections of the nail. The comp…

Articles about TOPICA Pharmaceuticals' Series B - II Round: